Search

Learn how an MSK laboratory is bringing much-needed focus to cancer-related lymphedema and investigating new ways to prevent the complication.

… Thursday, October 18, 2018 Summary Lymphedema caused by cancer treatment is an often-debilitating condition that can last for years or decades. A dedicated research laboratory at MSK is clarifying how this puzzling disease develops and testing new therapies that could reduce or prevent its effects. Lymphedema

In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.

… Thursday, May 30, 2013 Summary In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer. For the first time, structural biologists at Memorial Sloan Kettering have revealed the molecular structure of mTOR, a protein

A member of the Sloan Kettering Institute's Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system.

… Friday, October 1, 2010 Summary A member of the Sloan Kettering Institute’s Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system. A member of the Sloan

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.

… Thursday, August 10, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — found a potential target against neuroendocrine transformation in lung and prostate cancers; discovered n ew

A summer program offers college students from underrepresented communities a chance to get valuable research experience.

… Thursday, August 29, 2024 Every summer, curious college students have a chance to get a feel for what it’s like to be a cancer researcher. Memorial Sloan Kettering Cancer Center (MSK) chooses 10 students from underrepresented communities to participate in an 8-week internship called the Summer Clinical

Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research.

… Thursday, November 3, 2022 Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research. Since 1995, runners have joined Fred’s Team to add more meaning to their miles by raising money in support of lifesaving studies and clinical trials at

A new study from Memorial Sloan Kettering Cancer Center (MSK) provides important insights into cancer metastasis.  

… Thursday, February 3, 2022 New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK), and published today in the journal Cell , support an emerging framework in cancer science that views metastasis as not primarily driven by genetic mutations, but rather by epigenetic changes that

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

… Monday, October 31, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Luis Diaz Luis Diaz Jr. Recognized with a 2022 El Award by New York’s El Diario Luis Alberto Diaz, Jr., MD , medical oncologist, Head Division of Solid Tumor Oncology, and Grayer Family

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Tuesday, March 28, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: MSK Granted Merit Extension from the National Cancer Institute MSK was granted a prestigious two-year merit extension of its Cancer Center Support Grant from the National Cancer

The word “epigenetic” literally means “above the genes.” Calico cats demonstrate a type of epigenetic inheritance called X-inactivation.

… Tuesday, June 19, 2018 If you’ve ever known a set of identical twins, you might have been struck by what they didn’t have in common. Maybe one was a skilled musician, while the other couldn’t carry a tune. Maybe one craved adventure, while the other preferred the couch. These anecdotal examples reveal